TY  - JOUR
A1  - Nadella, Vinod
A1  - Mohanty, Aparna
A1  - Sharma, Lalita
A1  - Yellaboina, Sailu
A1  - Mollenkopf, Hans-Joachim
A1  - Mazumdar, Varadendra Balaji
A1  - Palaparthi, Ramesh
A1  - Mylavarapu, Madhavi B.
A1  - Maurya, Radheshyam
A1  - Kurukuti, Sreenivasulu
A1  - Rudel, Thomas
A1  - Prakash, Hridayesh
T1  - Inhibitors of Apoptosis Protein Antagonists (Smac Mimetic Compounds) Control Polarization of Macrophages during Microbial Challenge and Sterile Inflammatory Responses
JF  - Frontiers in Immunology
N2  - Apoptosis is a physiological cell death process essential for development, tissue homeostasis, and for immune defense of multicellular animals. Inhibitors of apoptosis proteins (IAPs) regulate apoptosis in response to various cellular assaults. Using both genetic and pharmacological approaches we demonstrate here that the IAPs not only support opportunistic survival of intracellular human pathogens like Chlamydia pneumoniae but also control plasticity of iNOS+ M1 macrophage during the course of infection and render them refractory for immune stimulation. Treatment of Th1 primed macrophages with birinapant (IAP-specific antagonist) inhibited NO generation and relevant proteins involved in innate immune signaling. Accordingly, birinapant promoted hypoxia, angiogenesis, and tumor-induced M2 polarization of iNOS+ M1 macrophages. Interestingly, birinapant-driven changes in immune signaling were accompanied with changes in the expression of various proteins involved in the metabolism, and thus revealing the new role of IAPs in immune metabolic reprogramming in committed macrophages. Taken together, our study reveals the significance of IAP targeting approaches (Smac mimetic compounds) for the management of infectious and inflammatory diseases relying on macrophage plasticity.
KW  - apoptosis
KW  - macrophages immunobiology
KW  - inflammation mediators
KW  - polarization
KW  - infection
KW  - hypothalamus
Y1  - 2018
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-197484
SN  - 1664-3224
VL  - 8
IS  - 1792
ER  - 
TY  - JOUR
A1  - Viera, Jonathan Trujillo
A1  - El-Merahbi, Rabih
A1  - Nieswandt, Bernhard
A1  - Stegner, David
A1  - Sumara, Grzegorz
T1  - Phospholipases D1 and D2 Suppress Appetite and Protect against Overweight
JF  - PLoS ONE
N2  - Obesity is a major risk factor predisposing to the development of peripheral insulin resistance and type 2 diabetes (T2D). Elevated food intake and/or decreased energy expenditure promotes body weight gain and acquisition of adipose tissue. Number of studies implicated phospholipase D (PLD) enzymes and their product, phosphatidic acid (PA), in regulation of signaling cascades controlling energy intake, energy dissipation and metabolic homeostasis. However, the impact of PLD enzymes on regulation of metabolism has not been directly determined so far. In this study we utilized mice deficient for two major PLD isoforms, PLD1 and PLD2, to assess the impact of these enzymes on regulation of metabolic homeostasis. We showed that mice lacking PLD1 or PLD2 consume more food than corresponding control animals. Moreover, mice deficient for PLD2, but not PLD1, present reduced energy expenditure. In addition, deletion of either of the PLD enzymes resulted in development of elevated body weight and increased adipose tissue content in aged animals. Consistent with the fact that elevated content of adipose tissue predisposes to the development of hyperlipidemia and insulin resistance, characteristic for the pre-diabetic state, we observed that Pld1\(^{-/-}\) and Pld2\(^{-/-}\) mice present elevated free fatty acids (FFA) levels and are insulin as well as glucose intolerant. In conclusion, our data suggest that deficiency of PLD1 or PLD2 activity promotes development of overweight and diabetes.
KW  - enzyme regulation
KW  - insulin resistance
KW  - body weight
KW  - mouse models
KW  - bioenergetics
KW  - insulin
KW  - hypothalamus
KW  - adipose tissue
Y1  - 2016
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-179729
VL  - 11
IS  - 6
ER  -